Chemoinformaics analysis of Docosyl pentafluoropropionate
| Molecular Weight | 472.623 | nRot | 22 |
| Heavy Atom Molecular Weight | 427.263 | nRig | 1 |
| Exact Molecular Weight | 472.334 | nRing | 0 |
| Solubility: LogS | -7.381 | nHRing | 0 |
| Solubility: LogP | 10.709 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 45 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 76.1447 |
| nHD | 0 | BPOL | 53.3133 |
| QED | 0.089 |
| Synth | 2.268 |
| Natural Product Likeliness | -0.106 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -5.217 |
| MDCK | 0.00000515 |
| BBB | 0.004 |
| PPB | 1.01778 |
| VDSS | 4.32 |
| FU | 0.00567819 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.159 |
| CYP2c19-inh | 0.18 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.062 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.123 |
| CYP2d6-sub | 0.035 |
| CYP3a4-inh | 0.231 |
| CYP3a4-sub | 0.041 |
| CL | 4.677 |
| T12 | 0.009 |
| hERG | 0.453 |
| Ames | 0.004 |
| ROA | 0.033 |
| SkinSen | 0.925 |
| Carcinogencity | 0.054 |
| EI | 0.908 |
| Respiratory | 0.661 |
| NR-Aromatase | 0.07 |
| Antiviral | Yes |
| Prediction | 0.768474 |